RedHill Biopharma (RDHL) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
RedHill Biopharma Ltd. has announced the postponement of its Annual General Meeting of Shareholders originally scheduled for September 17, 2024, due to not meeting the legal quorum requirements. The meeting has been rescheduled to take place on September 18, 2024, at the company’s offices in Israel. This information has been filed with the SEC and incorporated into the company’s existing Registration Statements.
For further insights into RDHL stock, check out TipRanks’ Stock Analysis page.